S1826 article heading
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma
Oct 11, 2024
Oct 4, 2024
Front Lines on important SWOG results make up some of my most popular posts
Oct 2, 2024
Custom facility consolidates five locations into one
Oct 2, 2024
In surgery for localized muscle-invasive bladder cancer, extended lymph node removal offers no survival benefit but does increase morbidity
Sep 27, 2024
The NCTN group chairs propose improvements in how we do correlative science
Sep 24, 2024
A new validated risk model identifies advanced cancer trial patients at highest risk for acute care use
Sep 20, 2024
Adding ruxolitinib to TKI treatment for chronic-phase chronic myeloid leukemia (CML) increases deep molecular response rate
Sep 20, 2024
S1712 finds adding ruxolitinib increases response to TKIs in CML